One more trial from the Swiss Group (SAKK) enrolled cytologically or histologically tested IIIA (N2) clients which have been then randomized into preoperative chemotherapy followed by surgical treatment versus sequential neo-adjuvant chemotherapy and then radiotherapy accompanied by medical procedures; the primary as well as secondary endpoints on